Author:
Carmona Martinez Alfonso,Prymula Roman,Miranda Valdivieso Mariano,Otero Reigada Maria del Carmen,Merino Arribas Jose Manuel,Brzostek Jerzy,Szenborn Leszek,Ruzkova Renata,Horn Michael R.,Jackowska Teresa,Centeno-Malfaz Fernando,Traskine Magali,Dobbelaere Kurt,Borys Dorota
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference38 articles.
1. Pneumococcal vaccines WHO position paper – 2012;World Health Organization;Wkly Epidemiol Rec,2012
2. 10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: synflorix;Prymula;Expert Rev Vaccines,2009
3. 13-valent pneumococcal conjugate vaccine: a review of its use in infants, children, and adolescents;Plosker;Paediatr Drugs,2013
4. Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study;Domingues;Lancet Respir Med,2014
5. International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. Pneumococcal conjugate vaccine (PCV) product assessment; April 2017. Available at [accessed 7 March 2018].